| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/THY.09.81 |
| 10.1186/1742-6405-7-27 | ||
| P953 | full work available at URL | https://europepmc.org/articles/PMC2920229 |
| https://europepmc.org/articles/pmc2920229?pdf=render | ||
| https://europepmc.org/articles/PMC2920229?pdf=render | ||
| P932 | PMC publication ID | 2920229 |
| P698 | PubMed publication ID | 20667109 |
| P50 | author | Chaoping Chen | Q59694846 |
| P2093 | author name string | Liangqun Huang | |
| P2860 | cites work | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 |
| Active human immunodeficiency virus protease is required for viral infectivity | Q24647696 | ||
| Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening | Q24651907 | ||
| Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates | Q24812175 | ||
| Darunavir | Q29037552 | ||
| pEF-BOS, a powerful mammalian expression vector | Q29547606 | ||
| Clinical and Laboratory Features of HumanPlasmodium knowlesiInfection | Q29999621 | ||
| Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial | Q33222370 | ||
| Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria | Q33303521 | ||
| Long term outcome of severe anaemia in Malawian children | Q33358084 | ||
| Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease. | Q33559311 | ||
| HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria | Q33785634 | ||
| Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection | Q33846683 | ||
| HIV-1 protease: maturation, enzyme specificity, and drug resistance. | Q34050688 | ||
| A structural model for the retroviral proteases. | Q34173510 | ||
| p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease | Q34288376 | ||
| Severe anemia in Malawian children | Q34588857 | ||
| UK malaria treatment guidelines | Q34600118 | ||
| Exchange transfusion for severe malaria | Q43598979 | ||
| Retinal changes in adults with cerebral malaria | Q44476377 | ||
| Iron and folate status in Gambian children with malaria | Q44655225 | ||
| Differentiating the pathologies of cerebral malaria by postmortem parasite counts | Q44772302 | ||
| Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins | Q45752917 | ||
| Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria | Q46355187 | ||
| Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions | Q46436480 | ||
| Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children | Q46579848 | ||
| A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures | Q46835635 | ||
| Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit | Q46904281 | ||
| Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. | Q47824850 | ||
| Bacteraemia complicating severe malaria in children | Q47853607 | ||
| Intracranial pressure in African children with cerebral malaria | Q47862115 | ||
| Blood transfusion for severe anaemia in children in a Kenyan hospital | Q47899901 | ||
| Dynamic alteration in splenic function during acute falciparum malaria | Q47912671 | ||
| Response to volume resuscitation in children with severe malaria | Q47968278 | ||
| Severe Hypoglycemia and Hyperinsulinemia in Falciparum Malaria | Q47976600 | ||
| Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients | Q47992354 | ||
| Salmonella bacteremia in Kenyan children | Q48024999 | ||
| Retinal findings predictive of outcome in cerebral malaria | Q48030587 | ||
| A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation. | Q52202674 | ||
| Complete mutagenesis of the HIV-1 protease | Q59066144 | ||
| Mutational and structural studies aimed at characterizing the monomer of HIV-1 protease and its precursor | Q80107609 | ||
| Electroencephalographic and clinical features of cerebral malaria | Q35269366 | ||
| Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein | Q35675295 | ||
| Mannitol as adjunct therapy for childhood cerebral malaria in Uganda: a randomized clinical trial | Q36286003 | ||
| Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. | Q36650046 | ||
| Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings | Q36835807 | ||
| Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya | Q37041446 | ||
| Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial | Q37105545 | ||
| Artesunate for the treatment of severe falciparum malaria | Q37147010 | ||
| Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication | Q37248021 | ||
| Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69. | Q37256706 | ||
| Rabies encephalitis in malaria-endemic area, Malawi, Africa | Q37302526 | ||
| N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial | Q37318283 | ||
| Kinetochore-microtubule attachment relies on the disordered N-terminal tail domain of Hec1. | Q37365711 | ||
| Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity | Q37480211 | ||
| Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1. | Q37522019 | ||
| New developments in the management of malaria in adults | Q37573181 | ||
| Retroviral proteinases | Q37950642 | ||
| Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial | Q38379646 | ||
| The epidemiology of malaria | Q39032774 | ||
| Severe anaemia in children living in a malaria endemic area of Kenya | Q39115654 | ||
| Dichloroacetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment | Q39148526 | ||
| Erythrocyte survival in severe falciparum malaria | Q39188629 | ||
| Indicators of life-threatening malaria in African children | Q39217563 | ||
| Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants | Q39244633 | ||
| A quantitative ultrastructural study of renal pathology in fatal Plasmodium falciparum malaria | Q39301901 | ||
| Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam | Q39354762 | ||
| Intracranial pressure in childhood cerebral malaria | Q39570693 | ||
| Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. | Q39579012 | ||
| Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity | Q39579642 | ||
| Cysteine 95 and other residues influence the regulatory effects of Histidine 69 mutations on Human Immunodeficiency Virus Type 1 protease autoprocessing | Q39724170 | ||
| Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation. | Q40005589 | ||
| Bacteremia in febrile Malawian children: clinical and microbiologic features | Q40622532 | ||
| Intravenous immunoglobulin in the treatment of paediatric cerebral malaria | Q40726044 | ||
| Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism | Q41275889 | ||
| Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles | Q41564861 | ||
| Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease | Q41997191 | ||
| Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial | Q42170063 | ||
| Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial | Q42685738 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 27 | |
| P577 | publication date | 2010-07-28 | |
| P1433 | published in | AIDS Research and Therapy | Q15755474 |
| P1476 | title | Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells | |
| P478 | volume | 7 |
| Q28546560 | A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity |
| Q37237447 | Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme |
| Q47553033 | Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors |
| Q48462323 | Development of psychotherapy. Establishment of the International Federation for Psychotherapy (IFP) and other organizations |
| Q38972969 | Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions |
| Q35022049 | Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors |
| Q47549362 | Modified Roller Tube Method for Precisely Localized and Repetitive Intermittent Imaging During Long-term Culture of Brain Slices in an Enclosed System |
| Q27306330 | TPC2 mediates new mechanisms of platelet dense granule membrane dynamics through regulation of Ca2+ release |
| Q61445564 | Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment |
| Q37233259 | The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility |
| Q33356201 | Understanding HIV-1 protease autoprocessing for novel therapeutic development |
Search more.